Plasma glycated CD59 (gCD59), a novel biomarker for the diagnosis, management and follow up of women with Gestational Diabetes (GDM) - protocol for prospective cohort study.

BMC Pregnancy and Childbirth
D BogdanetF Dunne

Abstract

The prevalence of Gestational Diabetes (GDM) is rising and with it the number of mothers and children at risk of adverse outcomes. As treatment has been shown to reduce adverse events, it is imperative that we identify all at-risk pregnant women. In Ireland, the national standard of care is selective screening with a 2-hour 75 g oral glucose tolerance test (OGTT). Aiming for universal screening is of utmost importance but this is difficult given the length, the unfeasibility and impracticability of the OGTT. We aim to assess if the novel biomarker glycated CD59 (gCD59) is a suitable contender for the OGTT in identifying women with GDM. In this prospective cohort study, the study participants will be consecutive pregnant women at Galway University Hospital, Galway, Ireland. Samples for the plasma gCD59 biomarker will be taken together with routine bloods at the first antenatal visit, at weeks 24-28 at the time of routine 75 g OGTT, in trimester 3- and 12-weeks post-partum for women with GDM while having their routine post-partum 75 g OGTT. The constructed database will contain baseline information on each study participant, baseline laboratory data, follow-up laboratory data and pregnancy related outcomes. We aim to recruit a to...Continue Reading

References

Oct 1, 1993·American Journal of Obstetrics and Gynecology·P M CatalanoS B Amini
Feb 17, 1997·The Journal of Experimental Medicine·J YuS Tomlinson
May 11, 2000·Proceedings of the National Academy of Sciences of the United States of America·J AcostaJ Halperin
Oct 16, 2002·Annals of the Rheumatic Diseases·J E SalmonV M Holers
Dec 25, 2003·Diabetes Research and Clinical Practice·M M AgarwalG S Dhatt
Jun 14, 2005·The New England Journal of Medicine·Caroline A CrowtherUNKNOWN Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group
Jul 19, 2005·Molecular Immunology·Guillermina GirardiFrancesco Tedesco
Aug 23, 2006·The Journal of Experimental Medicine·Guillermina GirardiJane E Salmon
Nov 6, 2007·Clinical Obstetrics and Gynecology·Boyd E Metzger
May 9, 2008·The New England Journal of Medicine·UNKNOWN HAPO Study Cooperative Research GroupDavid A Sacks
Jul 1, 2009·Diabetes Care·Robert G Moses, N Wah Cheung
Oct 3, 2009·The New England Journal of Medicine·Mark B LandonUNKNOWN Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network
Jan 26, 2010·Nature Reviews. Endocrinology·Chloe A Zera, Ellen W Seely
Jan 26, 2010·Nature Reviews. Endocrinology·Allan Flyvbjerg
Sep 26, 2012·Hypertension·Aletta BuurmaHans J Baelde
May 15, 2013·American Journal of Hematology·Pamela GhoshJose A Halperin
Oct 17, 2013·American Journal of Reproductive Immunology : AJRI·M Camille HoffmanVirginia D Winn
Mar 19, 2014·The Journal of Clinical Endocrinology and Metabolism·Pamela GhoshJose A Halperin
Sep 14, 2017·Seminars in Immunopathology·Guillermina Girardi
Sep 13, 2018·JAMA : the Journal of the American Medical Association·William L LoweUNKNOWN HAPO Follow-up Study Cooperative Research Group
Jan 19, 2019·Diabetes Care·William L LoweUNKNOWN HAPO Follow-up Study Cooperative Research Group

❮ Previous
Next ❯

Citations

May 1, 2021·Journal of Clinical Medicine·Delia BogdanetPaula M O'Shea

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay
SGA
ELISA

Related Concepts

Related Feeds

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.